Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived. - 2High velocity Internet services for Metropolitan Regions
- 3Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
- 4Russia accidentally destroys its only way of sending astronauts to space
- 5Manual for 10 Scrumptious Specialty Mixed drinks
- UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
- Sixteen Kenyans missing in Russia after army recruitment
- Venezuelans in Madrid celebrate Maduro's capture
- A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns
- Step by step instructions to Protect Your Senior Condo for Ideal Wellbeing and Solace
- Is new Harry Styles music on the way? Fans think so, after a cryptic website and posters pop up.
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’
- Australia to offer businesses $693 million in cheap loans to ease fuel cost pressure
